ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance

BACKGROUND: Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited treatment options and poor prognosis. This study aimed to identify potential therapeutic targets based on the expression profiles of differentially expressed genes (DEGs) in TNBC. METHODS: The Limma package w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chao, Xie, Yongjie, Xie, Peng, Li, Jianming, Tong, Zhongsheng, Yang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597932/
https://www.ncbi.nlm.nih.gov/pubmed/37875591
http://dx.doi.org/10.1007/s12672-023-00790-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597932/
https://www.ncbi.nlm.nih.gov/pubmed/37875591
http://dx.doi.org/10.1007/s12672-023-00790-4

Ejemplares similares